Manufacturer: 

Contents:

Oral Contraceptives Agents

Oral contraception.

Tablets must be taken in the order directed on the package everyday at about the same time with some liquid as needed. 1 tab is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free interval, during which time, a withdrawal bleed usually occurs. This usually starts on days 2-3 after the last tablet and may not have finished before the next pack is started.

Venous or arterial thromboembolic events including MI & CVA. Prodromi of thrombosis (transient ischaemic attack, angina pectoris), migraine w/ focal neurological symptoms, diabetes mellitus w/ vascular involvement. Severe or multiple risk factors for venous or arterial thrombosis. Pancreatitis, severe hepatic disease, benign or malignant liver tumours, renal impairment. Sex steroid-influenced malignant conditions of the genitals or breasts, undiagnosed vag bleeding. Severe dyslipoproteinemia, hypertension, hypercholesterolemia or hypertriglyceridemia. Coagulopathy. Pregnancy.

Circulatory thromboembolic disorders, tumours, diabetes, hypertension, dyslipoproteinaemia, valvular heart disease, atrial fibrillation, smoking, prolonged immobilisation, major surgery, or any surgery to the legs. Multiple sclerosis, otosclerosis, Sydenham's chorea, SLE, sickle cell anaemia, inflammatory bowel disease. Lactation.

Breast tenderness, pain & secretion, menstrual disorder, intermenstrual bleeding; headache; libido changes, depressive moods, migraine, hypertension, hypotension, thromboembolism, contact lens intolerance, GI disturbances, changes in vag secretion, skin reactions, fluid retention, wt changes, hypersensitivity reactions.

Hydantoins, barbiturates, primidone, carbamazepine, rifampicin, oxcarbazepine, topiramate, felbamate, griseofulvin, ampicillin, tetracyclines, erythromycin, cyclosporin.

Not established